SNYR
Synergy CHC Corp.
Key Financials
Operating Income
$-8458749
↓ 245.8%
Net Income
$-12341208
↓ 680.8%
Gross Profit
$20.3M
↓ 14.1%
Revenue
$30.4M
↓ 12.8%
EPS (Diluted)
$-1.27
↓ 553.6%
Total Assets
$10.2M
↓ 37.8%
Total Liabilities
$33.3M
↑ 1.0%
Shareholders' Equity
$-23128138.00
↓ 39.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/18/2026 | View on SEC |
| S-1 | 5/15/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
| 8-K | 5/11/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
| DEFA14A | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| 4 | 4/24/2026 | View on SEC |
| 4 | 4/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SNYR |
| Company Name | Synergy CHC Corp. |
| CIK | 1562733 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 615-939-9004 |